Bank Julius Baer & Co. Ltd, Zurich Adaptive Biotechnologies Corp Transaction History

Bank Julius Baer & Co. Ltd, Zurich

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	SELL	$10.12 - $28.9 $8,095 - $23,120	-800 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$30.02 - $39.87 $1.77 Million - $2.36 Million	-59,112 Reduced 98.66%	800 $27,000
Q2 2021 Jul 23, 2021	SELL	$32.22 - $44.59 $6.27 Million - $8.68 Million	-194,655 Reduced 76.47%	59,912 $2.45 Million
Q1 2021 May 10, 2021	BUY	$37.26 - $67.74 $5.31 Million - $9.66 Million	142,627 Added 127.41%	254,567 $10.2 Million
Q4 2020 Feb 24, 2021	SELL	$45.01 - $65.47 $143 Million - $209 Million	-3,186,251 Reduced 96.61%	111,940 $6.62 Million
Q4 2020 Feb 12, 2021	BUY	$45.01 - $65.47 $146 Million - $212 Million	3,242,796 Added 5853.95%	3,298,191 $6.62 Million
Q3 2020 Nov 10, 2020	BUY	$35.79 - $48.81 $694,540 - $947,206	19,406 Added 53.92%	55,395 $2.69 Million
Q2 2020 Aug 12, 2020	SELL	$24.95 - $48.38 $1,971 - $3,822	-79 Reduced 0.22%	35,989 $1.74 Million
Q1 2020 May 13, 2020	BUY	$16.96 - $34.16 $611,713 - $1.23 Million	36,068 New	36,068 $1 Million

201

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $670M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.